GenPharmaChain and Astrica Healthcare Collaborate on Letzrole Tablets GenPharmaChain has partnered with Astrica Healthcare to produce Letzrole tablets using our advanced blockchain-based healthcare tools. Astrica Healthcare, certified with ISO 9001:2015 and following WHO GMP standards, brings expertise from their API division, Aspen Bio Pharma Pvt Ltd. We’ve also completed the formulation unit for Astra Generics Pvt Ltd. This collaboration ensures high-quality production and transparency, setting a new standard in pharmaceutical manufacturing.

RT @BiologyAIDaily: A Technical Review of Multi-Omics Data Integration Methods: From Classical Statistical to Deep Generative Approaches 1…

RT @Genpharmachain: 🚀 OpenAI is pushing the boundaries of science! After the success of AlphaFold, they’ve just launched a groundbreaking p…

RT @PDBeurope: 364 new entries in #PDBrelease (! Here's the cryo-EM derived structure of the human GABAA receptor o…

RT @Genpharmachain: GenPharmachain offers an advanced platform that integrates various protein databases (such as UniProt and PDB) to delve…

🚀 OpenAI is pushing the boundaries of science! After the success of AlphaFold, they’ve just launched a groundbreaking protein engineering model that envisions a protein capable of transforming ordinary cells into stem cells—surpassing human limitations! 💪🔬 As AI and biotechnology converge, GenPharmaChain is at the forefront, ready to unlock the next wave of scientific breakthroughs alongside pioneers like OpenAI. The future of AI-driven medicine is here! 🌍🔬 #OpenAI #GenPharmaChain #ProteinEngineering #AI #Biotech #DrugDiscovery #ScientificRevolution #AIinHealthcare #Innovation #StemCells #AIandScience

🚀 Exciting Collaboration between GenPharmaChain and EdgeX! 🌐 GenPharmaChain is thrilled to partner with EdgeX, a trailblazer in Edge Computing, AI Agents, and Web3 technologies, to bring the future of healthcare and drug development to life! 🎉 EdgeX is building a decentralized, secure, and global infrastructure that empowers fast and efficient AI services worldwide. By combining edge computing with AI agents, EdgeX ensures real-time data processing and scalable solutions for industries like healthcare, biotech, and beyond. 💡⚡ At GenPharmaChain, we’re accelerating the drug discovery process with groundbreaking AI-powered tools like ADMET prediction and protein structure prediction, leveraging AI and blockchain to redefine biomedical research. 💊🔬 With access to over 70,000 protein records and 98M data points, we’re helping researchers predict protein functions, identify disease targets, and ultimately, fast-track drug development. 🚀 By integrating EdgeX's cutting-edge edge computing and AI capabilities, we’re unlocking new possibilities in real-time AI-powered drug development. EdgeX’s decentralized infrastructure will provide the computational power needed for deep learning algorithms, helping scientists and researchers process and analyze vast amounts of biological data at unprecedented speeds. 🔍💻

RT @DolphinXDAO: 🚀 Major breakthrough! Dolphin DAO joins forces with GenPharmaChain to drive the future of decentralized science (DeSci) an…

RT @BiologyAIDaily: Rag2Mol: Structure-based drug design based on Retrieval Augmented Generation • Rag2Mol introduces two workflows, Rag2M…

GenPharmachain offers an advanced platform that integrates various protein databases (such as UniProt and PDB) to delve deeply into protein sequences, structures, and functions. Leveraging bioinformatics and deep learning technologies, this platform not only provides detailed descriptions of protein sequences but also enables high-accuracy predictions of three-dimensional structures. This capability is crucial for uncovering functional domains, modification sites, and molecular interactions of proteins, providing a scientific foundation for researchers.

The global research market, valued at over $1.6 trillion, is plagued by inefficiencies, which Desci addresses using blockchain to democratize access and incentivise collaboration. High-profile supporters like Brian Armstrong, Vitalik Buterin, CZ, and firms like a16z have invested in Desci initiatives for years, driving projects like Molecule and VitaDAO to raise millions. With VC funding in blockchain-based health and science surpassing $800 million in 2024, Desci is emerging as a transformative force in science and innovation.

🚀 Exciting collaboration between GenPharmaChain and @EMC_Hub ! 🌐EMC_Hub, a leader in #AI and #DePIN in the #AI+Web3 space, is bridging computing power and AI (d)apps, with the world’s first GPU #RWA! 🎉 At GenPharmaChain, we're revolutionizing biomedical research by combining protein data with AI to accelerate drug discovery. 💊💡 From AI-powered ADMET Prediction to AI Protein Structure Prediction, we're paving the way for smarter, faster drug development. 🚀 With over 70,000 protein records and 98M data points, our platform empowers researchers to predict protein function and identify disease targets. 🔬💻 we will use EMC's GPU to support scientists with GPU power, and earn rewards for helping fit molecular structures. 🏆 Together, we aim to build a complete ecosystem for AI-driven drug development! 🌍💊 #AI #Web3 #DrugDiscovery #EMC #GenPharmaChain #Biotech #Innovation #RWA #Blockchain

RT @bravo_abad: PPdock: pocket prediction-based blind docking Computational methods that show how small molecules bind to proteins are cen…

RT @Genpharmachain: Each new dataset expands AI training base, improving prediction accuracy. We hope to integrate BIOMEDICA in the future…

RT @Genpharmachain: Find a paper discussing how multimodal AI integrates various data types, such as proteomics and electronic health recor…

RT @Genpharmachain: 🚀 Big thanks to @MENAFN for the amazing feature on Genpharmachain! 🙌 We're excited to break down barriers in the pharm…

RT @Genpharmachain: 🔬💊 Genpharmachain is enhancing drug development efficiency through advanced molecular ADMET (Absorption, Distribution,…

RT @Genpharmachain: 🚀🧬 Exciting to see breakthrough in protein-ligand binding! MaSIF-neosurf to design binders targeting new protein surfa…